# Oxybutynin

## Oxbu 5mg extended-release

##### 

| Title              | Content                                                                                                                            |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OOXB                                                                                                                               |
| Indications        | Relief of symptoms associated w/ voiding in patients w/ uninhibited neurogenic & reflex neurogenic bladder.                        |
| Dosing             | Initially， 5 mg once daily increased by 5 mg every week if necessary to the maximum 30 mg daily.                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                      |
| Contraindications  | Myasthenia gravis， glaucoma; GI obstruction， paralytic ileus， intestinal atony， megacolon， severe colitis; acute haemorrhage. |
| Adverse Effects    | Dry mouth， blurred vision， tachycardia， dizziness， impotence; allergic reactions.                                              |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                      |

